Anakinra and related drugs targeting interleukin-1 in the treatment of cryopyrin-associated periodic syndromes

Anakinra is an interleukin (IL) receptor antagonist that works by blocking the biological activity of IL-1 by competitively inhibiting binding of IL-1 to the type 1 interleukin receptor. IL-1 production is induced in response to inflammatory stimuli and mediates various physiological mechanisms, inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachove, Inessa, Chang, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045113/
https://www.ncbi.nlm.nih.gov/pubmed/27790031
http://dx.doi.org/10.2147/OARRR.S46017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045113/
https://www.ncbi.nlm.nih.gov/pubmed/27790031
http://dx.doi.org/10.2147/OARRR.S46017

Ejemplares similares